Product Images Divalproex Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Divalproex Sodium NDC 68071-4102 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

pdp - 68071 4102 03 U28

pdp - 68071 4102 03 U28

This is a description of a drug named Divalproex Sod. 250mg, provided in tablet form with an oval shape and pink color. The tablet is entenc-coated and delayed-release, with each containing Divalproex Sodium USP that is equivalent to Valproic acid at 250mg. The product is used only through prescriptions from licensed physicians. The description includes relevant details such as lot number, expiration date, NDC, and Rx number. There is a caution for keeping the drug out of children's reach, and it must be stored at a temperature between 63°F and 77°F.*

Structure - b937b05a c544 4ba2 9047 4b3e85f6c164 01

Structure - b937b05a c544 4ba2 9047 4b3e85f6c164 01

Comparison of percentage of patient separated by study - b937b05a c544 4ba2 9047 4b3e85f6c164 02

Comparison of percentage of patient separated by study - b937b05a c544 4ba2 9047 4b3e85f6c164 02

This appears to be a table with two study names with corresponding acronyms for measures used in each study - YMRS and MRS. It is unclear what the percentages at the top of the table refer to without additional context.*

% Reduction in CPS Rate Vs % of Patients - b937b05a c544 4ba2 9047 4b3e85f6c164 03

% Reduction in CPS Rate Vs % of Patients - b937b05a c544 4ba2 9047 4b3e85f6c164 03

The text represents a chart or graphic showing the percentage reduction in CPS rate for Divalproex Sodium and placebo. The chart also includes the percentage of patients who experienced improvement, no change, or worsening.*

% reduction in CPS Rate Vs % of Patients - b937b05a c544 4ba2 9047 4b3e85f6c164 04

% reduction in CPS Rate Vs % of Patients - b937b05a c544 4ba2 9047 4b3e85f6c164 04

Mean 4-week Migraine Rates - b937b05a c544 4ba2 9047 4b3e85f6c164 05

Mean 4-week Migraine Rates - b937b05a c544 4ba2 9047 4b3e85f6c164 05

This is a list of two clinical studies that involve Placebo and Divalproex® Sodium. The text seems to lack sufficient information to provide a more detailed description.*

Company Logo - b937b05a c544 4ba2 9047 4b3e85f6c164 06

Company Logo - b937b05a c544 4ba2 9047 4b3e85f6c164 06

This is a company named Unichem Pharmaceuticals (USA) Inc.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.